172 related articles for article (PubMed ID: 29843720)
1. Soluble epoxide hydrolase inhibitors, t-AUCB, downregulated miR-133 in a mouse model of myocardial infarction.
Gui Y; Li D; Chen J; Wang Y; Hu J; Liao C; Deng L; Xiang Q; Yang T; Du X; Zhang S; Xu D
Lipids Health Dis; 2018 May; 17(1):129. PubMed ID: 29843720
[TBL] [Abstract][Full Text] [Related]
2. Soluble epoxide hydrolase inhibitors might prevent ischemic arrhythmias via microRNA-1 repression in primary neonatal mouse ventricular myocytes.
Liu Q; Zhao X; Peng R; Wang M; Zhao W; Gui YJ; Liao CX; Xu DY
Mol Biosyst; 2017 Feb; 13(3):556-564. PubMed ID: 28112313
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of soluble epoxide hydrolase by trans-4- [4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury.
Chaudhary KR; Abukhashim M; Hwang SH; Hammock BD; Seubert JM
J Cardiovasc Pharmacol; 2010 Jan; 55(1):67-73. PubMed ID: 19834332
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation.
Liu JY; Tsai HJ; Hwang SH; Jones PD; Morisseau C; Hammock BD
Br J Pharmacol; 2009 Jan; 156(2):284-96. PubMed ID: 19154430
[TBL] [Abstract][Full Text] [Related]
5. Soluble epoxide hydrolase inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is neuroprotective in rat model of ischemic stroke.
Shaik JS; Ahmad M; Li W; Rose ME; Foley LM; Hitchens TK; Graham SH; Hwang SH; Hammock BD; Poloyac SM
Am J Physiol Heart Circ Physiol; 2013 Dec; 305(11):H1605-13. PubMed ID: 24043255
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches.
Li N; Liu JY; Timofeyev V; Qiu H; Hwang SH; Tuteja D; Lu L; Yang J; Mochida H; Low R; Hammock BD; Chiamvimonvat N
J Mol Cell Cardiol; 2009 Dec; 47(6):835-45. PubMed ID: 19716829
[TBL] [Abstract][Full Text] [Related]
7. Spironolactone Regulates HCN Protein Expression Through Micro-RNA-1 in Rats With Myocardial Infarction.
Yu HD; Xia S; Zha CQ; Deng SB; Du JL; She Q
J Cardiovasc Pharmacol; 2015 Jun; 65(6):587-92. PubMed ID: 26065643
[TBL] [Abstract][Full Text] [Related]
8. A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARĪ³ to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction.
Xu DY; Davis BB; Wang ZH; Zhao SP; Wasti B; Liu ZL; Li N; Morisseau C; Chiamvimonvat N; Hammock BD
Int J Cardiol; 2013 Aug; 167(4):1298-304. PubMed ID: 22525341
[TBL] [Abstract][Full Text] [Related]
9. Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice.
Roche C; Besnier M; Cassel R; Harouki N; Coquerel D; Guerrot D; Nicol L; Loizon E; Remy-Jouet I; Morisseau C; Mulder P; Ouvrard-Pascaud A; Madec AM; Richard V; Bellien J
Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1020-9. PubMed ID: 25724490
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-141 regulates the expression level of ICAM-1 on endothelium to decrease myocardial ischemia-reperfusion injury.
Liu RR; Li J; Gong JY; Kuang F; Liu JY; Zhang YS; Ma QL; Song CJ; Truax AD; Gao F; Yang K; Jin BQ; Chen LH
Am J Physiol Heart Circ Physiol; 2015 Oct; 309(8):H1303-13. PubMed ID: 26371161
[TBL] [Abstract][Full Text] [Related]
11. [Effects of soluble epoxide hydrolase inhibitors on the expression of fatty acid synthase in peripheral blood mononuclear cell of patients and inflammatory response with acute coronary syndrome].
Du JQ; Peng R; Xu DY; Zhao TT; Shen L; Zhao SP
Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(2):86-90. PubMed ID: 22490687
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection.
Lu Y; Zhang Y; Shan H; Pan Z; Li X; Li B; Xu C; Zhang B; Zhang F; Dong D; Song W; Qiao G; Yang B
Cardiovasc Res; 2009 Dec; 84(3):434-41. PubMed ID: 19581315
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1.
Shan H; Li X; Pan Z; Zhang L; Cai B; Zhang Y; Xu C; Chu W; Qiao G; Li B; Lu Y; Yang B
Br J Pharmacol; 2009 Nov; 158(5):1227-35. PubMed ID: 19775284
[TBL] [Abstract][Full Text] [Related]
14. Substituted phenyl groups improve the pharmacokinetic profile and anti-inflammatory effect of urea-based soluble epoxide hydrolase inhibitors in murine models.
Liu JY; Lin YP; Qiu H; Morisseau C; Rose TE; Hwang SH; Chiamvimonvat N; Hammock BD
Eur J Pharm Sci; 2013 Mar; 48(4-5):619-27. PubMed ID: 23291046
[TBL] [Abstract][Full Text] [Related]
15. Quercetin sensitizes glioblastoma to t-AUCB by dual inhibition of Hsp27 and COX-2 in vitro and in vivo.
Li J; Tang C; Li L; Li R; Fan Y
J Exp Clin Cancer Res; 2016 Apr; 35():61. PubMed ID: 27039073
[TBL] [Abstract][Full Text] [Related]
16. [Soluble epoxide hydrolase inhibitor t-AUCB ameliorates ox-LDL induced conversion of macrophages into foam cells through activating the PPARĪ³-ABCA1 pathway].
Zhao TT; Peng R; Shen L; Zhao X; Xu DY; Zhao SP
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Mar; 40(3):248-52. PubMed ID: 22801272
[TBL] [Abstract][Full Text] [Related]
17. Effects of soluble epoxide hydrolase inhibitor on the expression of fatty acid synthase in peripheral blood mononuclear cell in patients with acute coronary syndrome.
Zhao X; Du JQ; Xu DY; Zhao SP
Lipids Health Dis; 2013 Jan; 12():3. PubMed ID: 23305094
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart.
Dakhlallah D; Zhang J; Yu L; Marsh CB; Angelos MG; Khan M
J Cardiovasc Pharmacol; 2015 Mar; 65(3):241-51. PubMed ID: 25658461
[TBL] [Abstract][Full Text] [Related]
19. Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats.
Elmarakby AA; Faulkner J; Pye C; Rouch K; Alhashim A; Maddipati KR; Baban B
Clin Sci (Lond); 2013 Oct; 125(7):349-59. PubMed ID: 23611540
[TBL] [Abstract][Full Text] [Related]
20. MiR-223-3p as a Novel MicroRNA Regulator of Expression of Voltage-Gated K+ Channel Kv4.2 in Acute Myocardial Infarction.
Liu X; Zhang Y; Du W; Liang H; He H; Zhang L; Pan Z; Li X; Xu C; Zhou Y; Wang L; Qian M; Liu T; Yin H; Lu Y; Yang B; Shan H
Cell Physiol Biochem; 2016; 39(1):102-14. PubMed ID: 27322747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
